世界の腎臓/腎がん治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Kidney/Renal Cancer Drugs Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV01907)・商品コード:QYR20NV01907
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは腎臓/腎がん治療薬の世界市場について調査・分析した資料です。種類別(標的治療、化学治療、免疫治療)の市場規模、用途別(製薬会社、病院・診療所、民間・政府研究所、学術機関)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別腎臓/腎がん治療薬の競争状況、市場シェア
・世界の腎臓/腎がん治療薬市場:種類別市場規模 2015年-2020年(標的治療、化学治療、免疫治療)
・世界の腎臓/腎がん治療薬市場:種類別市場規模予測 2021年-2026年(標的治療、化学治療、免疫治療)
・世界の腎臓/腎がん治療薬市場:用途別市場規模 2015年-2020年(製薬会社、病院・診療所、民間・政府研究所、学術機関)
・世界の腎臓/腎がん治療薬市場:用途別市場規模予測 2021年-2026年(製薬会社、病院・診療所、民間・政府研究所、学術機関)
・北米の腎臓/腎がん治療薬市場分析:米国、カナダ
・ヨーロッパの腎臓/腎がん治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの腎臓/腎がん治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の腎臓/腎がん治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの腎臓/腎がん治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):F. Hoffmann、Bayer、Pfizer、Novartis
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Kidney/Renal Cancer Drugs are used to cure kidney cancers.
The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period.

Market Analysis and Insights: Global Kidney/Renal Cancer Drugs Market
The global Kidney/Renal Cancer Drugs market size is projected to reach US$ 4579.4 million by 2026, from US$ 4432.7 million in 2020, at a CAGR of 3.1%% during 2021-2026.

Global Kidney/Renal Cancer Drugs Scope and Market Size
Kidney/Renal Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kidney/Renal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Kidney/Renal Cancer Drugs market is segmented into
Targeted Therapy
Chemotherapy
Immunotherapy

Segment by Application, the Kidney/Renal Cancer Drugs market is segmented into
Drug Manufacturers
Hospitals and Clinics
Private and Government Research Institutes
Academic Institutes

Regional and Country-level Analysis
The Kidney/Renal Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Kidney/Renal Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Kidney/Renal Cancer Drugs Market Share Analysis
Kidney/Renal Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Kidney/Renal Cancer Drugs business, the date to enter into the Kidney/Renal Cancer Drugs market, Kidney/Renal Cancer Drugs product introduction, recent developments, etc.

The major vendors covered:
F. Hoffmann
Bayer
Pfizer
Novartis

【レポートの目次】

1 Study Coverage
1.1 Kidney/Renal Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Kidney/Renal Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Kidney/Renal Cancer Drugs Market Size Growth Rate by Type
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Immunotherapy
1.5 Market by Application
1.5.1 Global Kidney/Renal Cancer Drugs Market Size Growth Rate by Application
1.5.2 Drug Manufacturers
1.5.3 Hospitals and Clinics
1.5.4 Private and Government Research Institutes
1.5.5 Academic Institutes
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Kidney/Renal Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Kidney/Renal Cancer Drugs Revenue 2015-2026
2.1.2 Global Kidney/Renal Cancer Drugs Sales 2015-2026
2.2 Global Kidney/Renal Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Kidney/Renal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Kidney/Renal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Kidney/Renal Cancer Drugs Competitor Landscape by Players
3.1 Kidney/Renal Cancer Drugs Sales by Manufacturers
3.1.1 Kidney/Renal Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Kidney/Renal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Kidney/Renal Cancer Drugs Revenue by Manufacturers
3.2.1 Kidney/Renal Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Kidney/Renal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Kidney/Renal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Kidney/Renal Cancer Drugs Revenue in 2019
3.2.5 Global Kidney/Renal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Kidney/Renal Cancer Drugs Price by Manufacturers
3.4 Kidney/Renal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Kidney/Renal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Kidney/Renal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Kidney/Renal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Kidney/Renal Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Kidney/Renal Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Kidney/Renal Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Kidney/Renal Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Kidney/Renal Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Kidney/Renal Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Kidney/Renal Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Kidney/Renal Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Kidney/Renal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Kidney/Renal Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Kidney/Renal Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Kidney/Renal Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Kidney/Renal Cancer Drugs Price by Application (2015-2020)
5.2 Kidney/Renal Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Kidney/Renal Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Kidney/Renal Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Kidney/Renal Cancer Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Kidney/Renal Cancer Drugs by Country
6.1.1 North America Kidney/Renal Cancer Drugs Sales by Country
6.1.2 North America Kidney/Renal Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Kidney/Renal Cancer Drugs Market Facts & Figures by Type
6.3 North America Kidney/Renal Cancer Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Kidney/Renal Cancer Drugs by Country
7.1.1 Europe Kidney/Renal Cancer Drugs Sales by Country
7.1.2 Europe Kidney/Renal Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Kidney/Renal Cancer Drugs Market Facts & Figures by Type
7.3 Europe Kidney/Renal Cancer Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Kidney/Renal Cancer Drugs by Region
8.1.1 Asia Pacific Kidney/Renal Cancer Drugs Sales by Region
8.1.2 Asia Pacific Kidney/Renal Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Kidney/Renal Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Kidney/Renal Cancer Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Kidney/Renal Cancer Drugs by Country
9.1.1 Latin America Kidney/Renal Cancer Drugs Sales by Country
9.1.2 Latin America Kidney/Renal Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Kidney/Renal Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Kidney/Renal Cancer Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Kidney/Renal Cancer Drugs by Country
10.1.1 Middle East and Africa Kidney/Renal Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Kidney/Renal Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Kidney/Renal Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Kidney/Renal Cancer Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 F. Hoffmann
11.1.1 F. Hoffmann Corporation Information
11.1.2 F. Hoffmann Description and Business Overview
11.1.3 F. Hoffmann Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann Kidney/Renal Cancer Drugs Products Offered
11.1.5 F. Hoffmann Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Kidney/Renal Cancer Drugs Products Offered
11.2.5 Bayer Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Kidney/Renal Cancer Drugs Products Offered
11.3.5 Pfizer Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Kidney/Renal Cancer Drugs Products Offered
11.4.5 Novartis Related Developments
11.1 F. Hoffmann
11.1.1 F. Hoffmann Corporation Information
11.1.2 F. Hoffmann Description and Business Overview
11.1.3 F. Hoffmann Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann Kidney/Renal Cancer Drugs Products Offered
11.1.5 F. Hoffmann Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Kidney/Renal Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Kidney/Renal Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Kidney/Renal Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Kidney/Renal Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Kidney/Renal Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Kidney/Renal Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Kidney/Renal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Kidney/Renal Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Kidney/Renal Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Kidney/Renal Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Kidney/Renal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Kidney/Renal Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Kidney/Renal Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Kidney/Renal Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Kidney/Renal Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Kidney/Renal Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Kidney/Renal Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Kidney/Renal Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Kidney/Renal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Kidney/Renal Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Kidney/Renal Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Kidney/Renal Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Kidney/Renal Cancer Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Kidney/Renal Cancer Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Kidney/Renal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Kidney/Renal Cancer Drugs Market Segments
Table 2. Ranking of Global Top Kidney/Renal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Kidney/Renal Cancer Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Targeted Therapy
Table 5. Major Manufacturers of Chemotherapy
Table 6. Major Manufacturers of Immunotherapy
Table 7. Global Kidney/Renal Cancer Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Kidney/Renal Cancer Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Kidney/Renal Cancer Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Kidney/Renal Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Kidney/Renal Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Kidney/Renal Cancer Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Kidney/Renal Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Kidney/Renal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Kidney/Renal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Cancer Drugs as of 2019)
Table 16. Kidney/Renal Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Kidney/Renal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Kidney/Renal Cancer Drugs Price (2015-2020) (USD/Unit)
Table 19. Kidney/Renal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Kidney/Renal Cancer Drugs Product Type
Table 21. Date of International Manufacturers Enter into Kidney/Renal Cancer Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Kidney/Renal Cancer Drugs Sales Share by Type (2015-2020)
Table 25. Global Kidney/Renal Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Kidney/Renal Cancer Drugs Revenue Share by Type (2015-2020)
Table 27. Kidney/Renal Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Kidney/Renal Cancer Drugs Sales Share by Application (2015-2020)
Table 30. North America Kidney/Renal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Kidney/Renal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Kidney/Renal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Kidney/Renal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Kidney/Renal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Kidney/Renal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Kidney/Renal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Kidney/Renal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Kidney/Renal Cancer Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Kidney/Renal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Kidney/Renal Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Kidney/Renal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Kidney/Renal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Kidney/Renal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Kidney/Renal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Kidney/Renal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Kidney/Renal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Kidney/Renal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Kidney/Renal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Kidney/Renal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Kidney/Renal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Kidney/Renal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 70. F. Hoffmann Corporation Information
Table 71. F. Hoffmann Description and Major Businesses
Table 72. F. Hoffmann Kidney/Renal Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. F. Hoffmann Product
Table 74. F. Hoffmann Recent Development
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Major Businesses
Table 77. Bayer Kidney/Renal Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer Product
Table 79. Bayer Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Kidney/Renal Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Major Businesses
Table 87. Novartis Kidney/Renal Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Product
Table 89. Novartis Recent Development
Table 90. Global Kidney/Renal Cancer Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 91. Global Kidney/Renal Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 92. Global Kidney/Renal Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 93. Global Kidney/Renal Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 94. North America: Kidney/Renal Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 95. North America: Kidney/Renal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Europe: Kidney/Renal Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 97. Europe: Kidney/Renal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Asia Pacific: Kidney/Renal Cancer Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 99. Asia Pacific: Kidney/Renal Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 100. Latin America: Kidney/Renal Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 101. Latin America: Kidney/Renal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Middle East and Africa: Kidney/Renal Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 103. Middle East and Africa: Kidney/Renal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 105. Key Challenges
Table 106. Market Risks
Table 107. Main Points Interviewed from Key Kidney/Renal Cancer Drugs Players
Table 108. Kidney/Renal Cancer Drugs Customers List
Table 109. Kidney/Renal Cancer Drugs Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney/Renal Cancer Drugs Product Picture
Figure 2. Global Kidney/Renal Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Targeted Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Global Kidney/Renal Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Drug Manufacturers
Figure 8. Hospitals and Clinics
Figure 9. Private and Government Research Institutes
Figure 10. Academic Institutes
Figure 11. Kidney/Renal Cancer Drugs Report Years Considered
Figure 12. Global Kidney/Renal Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Kidney/Renal Cancer Drugs Sales 2015-2026 (K Units)
Figure 14. Global Kidney/Renal Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Kidney/Renal Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Kidney/Renal Cancer Drugs Sales Market Share by Region in 2019
Figure 17. Global Kidney/Renal Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Kidney/Renal Cancer Drugs Revenue Market Share by Region in 2019
Figure 19. Global Kidney/Renal Cancer Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Kidney/Renal Cancer Drugs Revenue in 2019
Figure 21. Kidney/Renal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Kidney/Renal Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Kidney/Renal Cancer Drugs Sales Market Share by Type in 2019
Figure 24. Global Kidney/Renal Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Kidney/Renal Cancer Drugs Revenue Market Share by Type in 2019
Figure 26. Global Kidney/Renal Cancer Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Kidney/Renal Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Kidney/Renal Cancer Drugs Sales Market Share by Application in 2019
Figure 29. Global Kidney/Renal Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Kidney/Renal Cancer Drugs Revenue Market Share by Application in 2019
Figure 31. North America Kidney/Renal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Kidney/Renal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Kidney/Renal Cancer Drugs Sales Market Share by Country in 2019
Figure 34. North America Kidney/Renal Cancer Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Kidney/Renal Cancer Drugs Market Share by Type in 2019
Figure 40. North America Kidney/Renal Cancer Drugs Market Share by Application in 2019
Figure 41. Europe Kidney/Renal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Kidney/Renal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Kidney/Renal Cancer Drugs Sales Market Share by Country in 2019
Figure 44. Europe Kidney/Renal Cancer Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Kidney/Renal Cancer Drugs Market Share by Type in 2019
Figure 56. Europe Kidney/Renal Cancer Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Kidney/Renal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Kidney/Renal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Kidney/Renal Cancer Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Kidney/Renal Cancer Drugs Revenue Market Share by Region in 2019
Figure 61. China Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Kidney/Renal Cancer Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Kidney/Renal Cancer Drugs Market Share by Application in 2019
Figure 85. Latin America Kidney/Renal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Kidney/Renal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Kidney/Renal Cancer Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Kidney/Renal Cancer Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Kidney/Renal Cancer Drugs Market Share by Type in 2019
Figure 96. Latin America Kidney/Renal Cancer Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Kidney/Renal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Kidney/Renal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Kidney/Renal Cancer Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Kidney/Renal Cancer Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Kidney/Renal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Kidney/Renal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Kidney/Renal Cancer Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Kidney/Renal Cancer Drugs Market Share by Application in 2019
Figure 109. North America Kidney/Renal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Kidney/Renal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Kidney/Renal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Kidney/Renal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Kidney/Renal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Kidney/Renal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Kidney/Renal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Kidney/Renal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Kidney/Renal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Kidney/Renal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed


【掲載企業】

F. Hoffmann、Bayer、Pfizer、Novartis

★調査レポート[世界の腎臓/腎がん治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV01907)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腎臓/腎がん治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆